Aplastic Anemia - Pipeline Review, H1 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Aplastic Anemia - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering.

This latest pipeline guide provides comprehensive information on the therapeutics under development for Aplastic Anemia (Hematological Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Aplastic Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Aplastic Anemia and features dormant and discontinued projects.

The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 3, 1, 3 and 1 respectively.

Companies Mentioned

  • Acceleron Pharma Inc
  • Amgen Inc
  • BioLineRx Ltd
  • F. Hoffmann-La Roche Ltd
  • Gamida Cell Ltd
  • Novartis AG
  • Regen BioPharma Inc

Key Topics Covered

  1. Introduction
  2. Report Coverage
  3. Aplastic Anemia - Overview
  4. Aplastic Anemia - Therapeutics Development
  5. Pipeline Overview
  6. Pipeline by Companies
  7. Products Under Development by Companies
  8. Aplastic Anemia - Therapeutics Assessment
  9. Assessment by Target
  10. Assessment by Mechanism of Action
  11. Assessment by Route of Administration
  12. Assessment by Molecule Type
  13. Aplastic Anemia - Companies Involved in Therapeutics Development
  14. Aplastic Anemia - Drug Profiles
  15. Aplastic Anemia - Dormant Projects
  16. Aplastic Anemia - Discontinued Products
  17. Aplastic Anemia - Product Development Milestones
  18. Featured News & Press Releases

For more information about this report visit https://www.researchandmarkets.com/research/gkhdlk/aplastic_anemia?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs